payor coverage Mar 15, 2022 OneOncology, Employer Direct Healthcare Aim to Improve Value-Based Precision Cancer Care Access Feb 11, 2022 Healthcare Stakeholders Redefine Cancer Multigene Testing Clinical Utility Hoping to Spur Adoption Premium May 17, 2021 Oncologists, Patients Still Face Unpredictable Payor Coverage for Broad Tissue NGS Panels Premium Jan 20, 2021 CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon Oct 19, 2020 CMS Colon Cancer Screening Memo Bodes Well for Assays in Development; Denies Epi ProColon Oct 15, 2020 Germany Grants National Reimbursement for Three Additional Breast Cancer Biomarker Tests Jul 8, 2020 Payor Policy Study Reveals Progress, Challenges in Liquid Biopsy Reimbursement Aug 26, 2019 Stakeholders Voice Concerns, Push Back on NCD for NGS Cancer Panels Premium Jun 20, 2019 NICE Guidance Recommends Amgen's Blincyto for ALL Patients in Remission Apr 10, 2019 Guardant Health Liquid Biopsy Test to be Covered by EviCore Feb 1, 2019 Precision Medicine Platform for Oncology Aims to Streamline Molecular Testing, Therapy Decision-Making Premium Feb 7, 2018 UK's NICE Finalizing Updated Breast Cancer Test Guidance Following Stakeholder Comments Premium May 30, 2017 Q&A: Winship Cancer Institute's Dan Brat on the Challenges of Using MDx for Cancer Premium Breaking News In Brief This Week: Gilead Sciences, Arcus Biosciences, Verismo Therapeutics, Caris Life Sciences Pyxis Oncology Gets FDA Permission to Start Phase I Trials of Anti-EDB Drug, Immunotherapy FDA Approves Rigel Pharmaceuticals' Rezlidhia for IDH1-Mutant AML Sofie Biosciences to Begin Trial of Fluorine-Labeled PET Diagnostic Imaging Agent for GI Cancers Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer Carrick Therapeutics Receives $35M Investment From Pfizer; Raises $25M in Series C Funding Round
